Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Parenteral Drugs (India) has informed that it has enclosed the Confirmation Certificate for dematerialization requests, cancellation of certificates and consequential actions, if any, as received from Link Intime India, RTA of the Company for the fourth quarter of the financial year 2020-21 ended on 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.